Regulatory Hurdles in the Commercialization of 3D Printed Pharmaceuticals and Medical Devices

Authors

  • Kusuma Lalitha.A, Raghava.D, Nageswara rao.K, Naga Sravani.P Author

DOI:

https://doi.org/10.48047/

Keywords:

3D Printing in Healthcare, Pharmaceutical Regulation, Medical Device Commercialization, Additive Manufacturing, Regulatory Challenges

Abstract

The emergence of 3D printing in the pharmaceutical and medical device sectors has revolutionized personalized medicine, enabling patient-specific dosages, tailored drug delivery systems, and customized implants. Despite its promise, the transition from innovation to market is constrained by significant regulatory challenges.

Downloads

Download data is not yet available.

Downloads

Published

2025-10-07

Issue

Vol. 16 No. 10 (2025): Volume 16 Issue 10 (2025)

Section

Articles